Mesenchymal stem cells and cardiac repair

被引:90
作者
Nesselmann, Catharina [1 ]
Ma, Nan [1 ]
Bieback, Karen [2 ]
Wagner, Wolfgang [3 ]
Ho, Anthony [3 ]
Konttinen, Yrjo T. [4 ]
Zhang, Hao [5 ,6 ]
Hinescu, Mihail E. [7 ,8 ]
Steinhoff, Gustav [1 ]
机构
[1] Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany
[2] Heidelberg Univ, Inst Transfus Med & Immunol, Med Fac Mannheim, German Red Cross Blood Donor Serv Baden Wurttembe, D-6900 Heidelberg, Germany
[3] Heidelberg Univ, Med Klin 5, D-6900 Heidelberg, Germany
[4] Biomedicum Helsinki, Helsinki, Finland
[5] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China
[7] Carol Davila Univ Med & Pharm, Dept Cellular & Mol Med, Bucharest, Romania
[8] Victor Babes Natl Inst Pathol, Bucharest, Romania
关键词
mesenchymal stem cells; ICLCs; regenerative medicine; heart muscle; repair mechanisms; ex vivo cell manipulation;
D O I
10.1111/j.1582-4934.2008.00457.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulating clinical and experimental evidence indicates that mesenchymal stem cells (MSCs) are promising cell types in the treatment of cardiac dysfunction. They may trigger production of reparative growth factors, replace damaged cells and create an environment that favours endogenous cardiac repair. However, identifying mechanisms which regulate the role of MSCs in cardiac repair is still at work. To achieve the maximal clinical benefits, ex vivo manipulation can further enhance MSC therapeutic potential. This review focuses on the mechanism of MSCs in cardiac repair, with emphasis on ex vivo manipulation.
引用
收藏
页码:1795 / 1810
页数:16
相关论文
共 138 条
[1]   Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro [J].
Åberg, ND ;
Blomstrand, F ;
Åberg, MAL ;
Björklund, U ;
Carlsson, B ;
Carlsson-Skwirut, C ;
Bang, P ;
Eriksson, PS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (01) :12-22
[2]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[3]   Bone loss and bone size after menopause [J].
Ahlborg, HG ;
Johnell, O ;
Turner, CH ;
Rannevik, G ;
Karlsson, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :327-334
[4]   Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo [J].
Al-Khaldi, A ;
Eliopoulos, N ;
Martineau, D ;
Lejeune, L ;
Lachapelle, K ;
Galipeau, J .
GENE THERAPY, 2003, 10 (08) :621-629
[5]  
[Anonymous], 2008, SAFETY EFFECTIVENESS
[6]   Steps toward mapping the human vasculature by phage display [J].
Arap, W ;
Kolonin, MG ;
Trepel, M ;
Lahdenranta, J ;
Cardó-Vila, M ;
Giordano, RJ ;
Mintz, PJ ;
Ardelt, PU ;
Yao, VJ ;
Vidal, CI ;
Chen, L ;
Flamm, A ;
Valtanen, H ;
Weavind, LM ;
Hicks, ME ;
Pollock, RE ;
Botz, GH ;
Bucana, CD ;
Koivunen, E ;
Cahill, D ;
Troncoso, P ;
Baggerly, KA ;
Pentz, RD ;
Do, KA ;
Logothetis, CJ ;
Pasqualini, R .
NATURE MEDICINE, 2002, 8 (02) :121-127
[7]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[8]   Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature [J].
Au, Patrick ;
Tam, Joshua ;
Fukumura, Dai ;
Jain, Rakesh K. .
BLOOD, 2008, 111 (09) :4551-4558
[9]   Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit [J].
Aupperle, H. ;
Garbade, J. ;
Schubert, A. ;
Barten, M. ;
Dhein, S. ;
Schoon, H.-A. ;
Mohr, F.-W. .
VETERINARY PATHOLOGY, 2007, 44 (04) :494-503
[10]   Modulation of integrins and integrin signaling molecules in the pressure-loaded murine ventricle [J].
Babbitt, CJ ;
Shai, SY ;
Harpf, AE ;
Pham, CG ;
Ross, RS .
HISTOCHEMISTRY AND CELL BIOLOGY, 2002, 118 (06) :431-439